Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ute Gravemann
Observed names:
Gravemann, Ute,
U. Gravemann
Institution:
German Red Cross
Observed institutions:
University of Veterinary Medicine Hannover, Foundation,
German Red Cross,
Medizinische Hochschule Hannover,
Universität Greifswald,
Helmholtz Centre for Infection Research,
Center for Experimental and Clinical Infection Research
show all 6
ORCID:
0000-0001-9050-1295
Observed ORCID:
0000-0001-9050-1295
OpenAlex ID:
A5025163389
Inactivation of three emerging viruses – severe acute respiratory syndrome coronavirus, Crimean–Congo haemorrhagic fever virus and Nipah virus – in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light
2020
·
Markus Eickmann
, Ute Gravemann
, et al.
·
Vox Sanguinis
·
153
PDF
BLOOD COMPONENTS: A novel approach to pathogen reduction in platelet concentrates using short‐wave ultraviolet light
2009
·
Harald Mohr
, Leif Steil
, et al.
·
Transfusion
·
152
Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively
2018
·
Markus Eickmann
, Ute Gravemann
, et al.
·
Transfusion
·
121
PDF
Sterilization of platelet concentrates at production scale by irradiation with short‐wave ultraviolet light
2009
·
Harald Mohr
, Ute Gravemann
, et al.
·
Transfusion
·
66
Two pathogen reduction technologies—methylene blue plus light and shortwave ultraviolet light—effectively inactivate hepatitis C virus in blood products
2012
·
Eike Steinmann
, Ute Gravemann
, et al.
·
Transfusion
·
61
West Nile virus in plasma is highly sensitive to methylene blue–light treatment
2004
·
Harald Mohr
, Joseph Knüver‐Hopf
, et al.
·
Transfusion
·
56
Elimination and multiplication of bacteria during preparation and storage of buffy coat–derived platelet concentrates
2006
·
Harald Mohr
, Anette Bayer
, et al.
·
Transfusion
·
48
Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light
2016
·
Helen M. Faddy
, Jesse J. Fryk
, et al.
·
Transfusion
·
45
Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light
2017
·
Jesse J. Fryk
, Denese C. Marks
, et al.
·
Transfusion
·
39
Bacterial inactivation of platelet concentrates with the THERAFLEX UV‐Platelets pathogen inactivation system
2018
·
Ute Gravemann
, Wiebke Handke
, et al.
·
Transfusion
·
31
Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid
2004
·
Martin Michaelis
, Nezira Köhler
, et al.
·
Biochemical Pharmacology
·
30
Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure
2015
·
Stephanie Pfaender
, Stephanie Walter
, et al.
·
Journal of General Virology
·
26
Hydroxamic acid and fluorinated derivatives of valproic acid: Anticonvulsant activity, neurotoxicity and teratogenicity
2008
·
Ute Gravemann
, Jutta Volland
, et al.
·
Neurotoxicology and Teratology
·
25
Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light
2009
·
Harald Mohr
, Ute Gravemann
, et al.
·
Transfusion
·
24
PDF
Automated in Vitro Screening of Teratogens
2002
·
Peter S. Walmod
, Anton Berezin
, et al.
·
Toxicology and Applied Pharmacology
·
24
Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light
2019
·
Helen M. Faddy
, Jesse J. Fryk
, et al.
·
Transfusion
·
19
Ultraviolet C light efficiently inactivates nonenveloped hepatitis A virus and feline calicivirus in platelet concentrates
2018
·
Ute Gravemann
, Wiebke Handke
, et al.
·
Transfusion
·
17
Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light
2020
·
Dimas Praditya
, Martina Friesland
, et al.
·
Vox Sanguinis
·
16
Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System
2009
·
Ute Gravemann
, Manuela Kusch
, et al.
·
Transfusion Medicine and Hemotherapy
·
15
PDF
Discriminative power of an assay for automated in vitro screening of teratogens
2004
·
Peter S Walmod
, Ute Gravemann
, et al.
·
Toxicology in Vitro
·
15
Growth and Distribution of Bacteria in Contaminated Whole Blood and Derived Blood Components
2024
·
Ute Gravemann
, Wiebke Handke
, et al.
·
Transfusion Medicine and Hemotherapy
·
14
PDF
Mitochondrial DNA multiplex real‐time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentrates
2017
·
Sinyoung Kim
, Wiebke Handke
, et al.
·
Transfusion
·
14
Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC‐treated platelet concentrates
2016
·
P. F. van der Meer
, U. Gravemann
, et al.
·
Vox Sanguinis
·
14
In vitro variables of buffy coat–derived platelet concentrates with residual plasma of down to 10% are stably maintained in new‐generation platelet additive solutions
2015
·
Ute Gravemann
, Thorsten Volgmann
, et al.
·
Transfusion
·
12
Proliferation of psychrotrophic bacteria in cold‐stored platelet concentrates
2024
·
Sandra Ramirez‐Arcos
, Dilini Kumaran
, et al.
·
Vox Sanguinis
·
10
Show more works
View as search
Works count:
42
Citation count:
1,120
H-index:
17
I10-index:
26
Year
Topic
Type
